Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trial

Peer Review reports

Original Submission
14 Feb 2024	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
8 Mar 2024	Author responded	Author comments - Graham McIlroy
Resubmission - Version 3
8 Mar 2024	Submitted	Manuscript version 3
Publishing
12 Mar 2024	Editorially accepted
25 Mar 2024	Article published	10.1186/s12885-024-12112-0

Back to article page